Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in non-small-cell lung cancer
Authors
Haslett, KateBlackhall, Fiona H
Koh, P
Ashcroft, Linda
Asselin, M
Dive, Caroline
Harris, C
Jackson, Alan
Manoharan, Prakash
Mullan, Damian
Ryder, W David J
Taylor, Benjamin
Faivre-Finn, Corinne
Affiliation
Oncology, The University of Manchester, and The Christie NHS Foundation Trust, ManchesterIssue Date
2018-01
Metadata
Show full item recordCitation
Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in non-small-cell lung cancer 2018, 115:S65 Lung CancerJournal
Lung CancerDOI
10.1016/S0169-5002(18)30177-6Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0169500218301776Type
Meetings and ProceedingsLanguage
enISSN
01695002ae974a485f413a2113503eed53cd6c53
10.1016/S0169-5002(18)30177-6